Ensuring compliance with mammography standards apparently takes up a big chunk of the Food and Drug Administration's time. In January and February, nearly 34% of the warning letters issued by the FDA involved "serious" regulatory compliance problems with mammography standards, according to a review by regulatory compliance firm NetCompliance of Washington, DC.
Of the 84 warning letters the FDA listed today for February, 29 warned of operations compliance problems ranging from missing records to a lack of educational experience by the interpreting physician. In January, 34 of 102 FDA warning letters dealt with mammography compliance problems, according to NetCompliance.
By AuntMinnie.com staff writersMarch 27, 2001
Related Reading
U.S. senators introduce bill to raise screening mammography payments 30%, March 19, 2001
U.S. mammography procedures grow 6% in 2000, March 9, 2001
Film-screen mammography remains gold standard, IOM says, March 8, 2001
Copyright © 2001 AuntMinnie.com
